SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Kornblith AB. Psychosocial adaptation of cancer survivors. In: Holland JC. Psycho-oncology. New York: Oxford University Press, 1998: 223254.
  • 2
    Lasry JCM, Margolese RG, Poisson R, et al. Depression and body image following mastectomy and lumpectomy. J Chronic Dis. 1987; 40: 529534.
  • 3
    Sneeuw KCA, Aaronson NK, Yarnold JR, et al. Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 2. Relationship with psychosocial functioning. Radiother Oncol. 1992; 25: 160166.
  • 4
    Glanz K, Lerman C. Psychosocial impact of breast cancer: a critical review. Ann Behav Med. 1992; 14: 204212.
  • 5
    Moyer A. Psychosocial outcomes of breast-conserving surgery versus mastectomy: a meta-analytic review. Health Psychol. 1997; 16: 284298.
  • 6
    Kiebert GM, de Haes JCJM, van de Velde CJH. The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review. J Clin Oncol. 1991; 9: 10591070.
  • 7
    Weiss RB, Korzun AH, Tormey DC, Holland JF, Rice MA, Wood WC. Adjuvant chemotherapy for breast carcinoma using CMFVP versus CMF versus CMF-MER: the nine year results for patients with 1–3 axillary nodes. In: SalmonSE, JonesSE, editors. Adjuvant therapy for cancer (5th edition). New York: Grune & Stratton, 1987: 327336.
  • 8
    Kornblith AB, Holland JC. A model for quality-of-life research from the Cancer and Leukemia Group B: the telephone interview, conceptual approach to measurement, and theoretical framework. J Natl Cancer Inst Monogr. 1996; 20: 5562.
  • 9
    Kornblith AB, Herndon J, Zuckerman E, et al. Comparison of long-term psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Ann Oncol. 1998; 9: 297306.
  • 10
    Kornblith AB, Herndon JE, Silverman LR, et al. The impact of 5-azacytidine on the quality of life of patients with the myelodysplastic syndrome (MDS) treated in a randomized Phase III trial of the Cancer and Leukemia Group B (CALGB). J Clin Oncol. 2002; 20: 24412452.
  • 11
    Greenberg DB, Kornblith AB, Herndon JE, et al. Quality of life of adult leukemia survivors treated on clinical trials of the Cancer and Leukemia Group B from 1971–1988: predictors for later psychological distress. Cancer. 1997; 80: 19361944.
  • 12
    Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment for Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85: 365376.
  • 13
    Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med. 1983; 13: 595605.
  • 14
    Weathers FW, Litz BT, Herman DS, Huska JA, Keane TM. The PTSD Checklist (PCL): reliability, validity, and diagnostic utility. Annual Meeting of the International Society for Traumatic Stress Studies; San Antonio, Texas; October 2427, 1993.
  • 15
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th edition). Washington DC: American Psychiatric Association, 1994.
  • 16
    Cella DF, Pratt A, Holland JC. Persistent anticipatory nausea, vomiting, and anxiety in cured Hodgkin's disease patients after completion of chemotherapy. Am J Psychiatry. 1986; 143: 641643.
  • 17
    Kornblith AB, Anderson J, Cella DF, et al. Hodgkin's disease survivors at increased risk for problems in psychosocial adaptation. Cancer. 1992; 70: 22142224.
  • 18
    Fillenbaum GG. Multidimensional functional assessment of older adults. The Duke older Americans resources and services procedures. Hillsdale, NJ: Lawrence Erlbaum, 1988.
  • 19
    Siegel K, Raveis VH, Mor V, Houts P. The relationship of spousal caregiver burden to patient disease and treatment-related conditions. Ann Oncol. 1991; 2: 511516.
  • 20
    Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991; 32: 705714.
  • 21
    Sarason IG, Johnson JH, Siegel JM. Assessing the impact of life changes: development of the Life Experiences Survey. J Consult Clin Psychol. 1978; 46: 932946.
  • 22
    Davies AR, Ware JE. GHAA's consumer satisfaction survey and user's manual. Washington: Group Health Association of America, 1991.
  • 23
    Holland JC, Herndon J, Kornblith AB, et al. A sociodemographic data collection model for cooperative clinical trials [abstract]. Proc Am Soc Clin Oncol. 1992; 11: 157.
  • 24
    King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res. 1996; 5: 555567.
  • 25
    Kwan W, Jackson J, Weir LM, et al. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol. 2002; 20: 42424248.
  • 26
    Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001; 92: 13681377.
  • 27
    Hack TF, Cohen L, Katz J, Robson LS, Goss P. Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol. 1999; 17: 143149.
  • 28
    De Girolamo G, McFarlane AC. The epidemiology of PTSD: a comprehensive review of the international literature. In: MarsellaAJ, FriedmanMJ, GerrityET, ScurfieldRM, editors. Ethnocultural aspects of posttraumatic stress disorder: issues, research and clinical applications. Washington DC: American Psychological Association, 1996: 3386.
  • 29
    Meyer L, Aspegren K. Long-term psychological sequelae of mastectomy and breast conserving treatment for breast cancer. Acta Oncol. 1989; 28: 1318.
  • 30
    Ganz PA, Desmond KA, Relin TR, Meyrowitz BE, Rowland JH. Predictors of sexual health in women after a breast cancer diagnosis. J Clin Oncol. 1999; 17: 23712380.
  • 31
    Kornblith AB, Herndon JE, Zuckerman E, et al. Social support as a buffer to the psychological impact of stressful life events in women with breast cancer. Cancer. 2001; 91: 443454.
  • 32
    Tejeda HA, Green SB, Trimble EL, et al. Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst. 1996; 88: 812816.